The transcription factor E2F1 has pivotal roles in both cell proliferation and cell death, and is an important molecular target in cancer. Under proliferative conditions E2F1 induces the expression of genes that promote cell cycle progression, such as E2F2, whereas under proapoptotic conditions E2F1 induces expression of genes such as p73 that lead to apoptosis. The mechanism by which the apoptotic function of E2F1 is activated remains unclear, however. We now show that members of the E2F family are covalently conjugated with the ubiquitin-like modifier NEDD8. Overexpression of SENP8, a NEDD8-specific cysteine protease, resulted in deNEDDylation of E2F1 and promoted its transactivation activity at the p73 gene but not at the E2F2 gene. Knockdown of SENP8, on the other hand, attenuated p73 expression and apoptosis induced by E2F1 or by DNA damage. SENP8 also promoted the interaction between E2F1 and its cofactor Microcephalin 1, which is required for p73 induction. These results suggest that NEDDylation is a molecular trigger that modifies the target specificity of E2F1, and could have important implications for E2F1 regulation of apoptosis.
INTRODUCTION
The E2F family of transcription factors is important for cellular homeostasis and the G 1 -S transition of the cell cycle. The family comprises eight members, among which E2F1, E2F2 and E2F3 constitute the transcriptional activator subfamily. These 'activator E2Fs' have a central role in coordinating cell cycle progression at the G 1 -to-S phase transition. Each of these activator E2Fs is able to promote cell cycle progression by activating target genes required for the G 1 -S transition and DNA replication. [1] [2] [3] [4] Ablation of all three activator E2Fs impairs progression through the G 1 -S transition, 5 although their relative contributions to cell cycle progression appears to vary by cell type. 6, 7 The activity of these E2Fs is tightly controlled throughout the cell cycle, largely through cell cyclespecific regulation of expression patterns and through modulation of the interaction of E2Fs with the retinoblastoma (pRB) tumorsuppressor proteins.
Paradoxically, in addition to regulating cell cycle progression the activator E2Fs also promote apoptosis by inducing the transcription of proapoptotic genes such as p73, [8] [9] [10] Bcl-2 homology region 3-only proteins, 11, 12 Apaf-1, 13 and caspases. 14 Among the activator E2Fs, E2F1 is thought to be the most important for apoptosis induction, as its abundance and activity are increased in response to DNA damage and other propapoptotic conditions. [15] [16] [17] [18] Given that cell proliferation accompanies an accumulation of E2F1, the transcriptional activity of E2F1 at proapoptotic genes must be blocked in order for cells to advance through the cell cycle. The mechanisms regulating the proapoptotic activity of E2F1 are not fully understood, although both post-translational modifications of E2F1 such as phosphorylation [19] [20] [21] and acetylation, 22 and selective interaction of E2F1 with transcriptional cofactors such as Jab1 15 and Microcephalin 1 (MCPH1) 23 have been implicated in selective activation of proapoptitic E2F1
target genes. In this study, we explore the mechanism underlying E2F1 transcriptional selectivity following DNA damage. NEDD8 is a member of the ubiquitin-like protein family and is covalently attached to the lysine residues of its substrates by a system of enzymes analogous to that responsible for ubiquitination. Several targets for NEDDylation have been characterized so far, 24 the effects of NEDD8 conjugation on its substrates remain largely unknown.
In the present study, we describe NEDDylation as a molecular modification on E2F1 that inhibits its proapoptotic transcriptional activity in the absence of DNA damage. We show that sentrinspecific protease 8 (SENP8; also known as NEDP1 and DEN1), a cysteine protease that specifically cleaves NEDD8 from modified substrates, removes NEDD8 from E2F1 following DNA damage. DeNEDDylation by SENP8 reinforces the interaction between E2F1 and MCPH1, and enhances E2F1 activity at a subset of target genes including p73. Furthermore, we show that SENP8, whose expression is increased in cells with damaged DNA, 25 is required for upregulation of the interaction between E2F1 and MCPH1, as well as for induction of p73 expression and apoptosis in response to DNA damage. Taken together, these results suggest that deNEDDylation is a critical switch that directs E2F1 toward proapoptotic function. This reveals a novel downstream effect of NEDD8 conjugation, and uncovers a new mechanism by which E2F1 promotes apoptosis following DNA damage.
RESULTS

E2Fs are conjugated with NEDD8 in vivo
We were interested in studying post-translational modifications on E2F1 that are necessary for promoting apoptosis in response to DNA damage. Acetylation of E2F1 was previously shown to be required for its recruitment to the promoter of the p73 gene, 22 a gene that is required for the induction of apoptosis by E2F1 in certain cell types. However, we found that a mutant form of E2F1 in which lysine residues targeted for acetylation are replaced with arginines activated the p73 gene promoter to the same extent as wild-type E2F1 (data not shown). We therefore searched for other post-translational modifications of E2F1 that might account for its qualitative shift in function in response to DNA damage.
Given that E2F1 was previously shown to be modified with ubiquitin 26, 27 and with the ubiquitin-related protein SUMO-1, 28 we asked whether E2F1 is also modified with the ubiquitin-related modifier NEDD8. We expressed E2F1 and His 6 -tagged forms of ubiquitin or NEDD8 in HEK293T. The cells were then lysed under denaturing conditions, and His 6 -tagged proteins were precipitated with affinity resin and subjected to immunoblot with antibodies to E2F1. We identified strong bands that migrated more slowly compared with the original E2F1 when His 6 -NEDD8 was expressed (Figure 1a ), suggesting that E2F1 was covalently modified with NEDD8 in vivo. Similar results were obtained for E2F2, E2F3, E2F4 or DP1 (Supplementary Figure S1A-D) . By contrast, the retinoblastoma protein pRB (Supplementary Figure S1E) , a well-established binding partner of E2Fs, as well as a deubiquitinase that regulates p53 (HAUSP) (Supplementary Figure S1F) , a deubiquitinase that regulates p53, were not NEDDylated under the same conditions. In addition, detection of ectopically expressed 3 Â FLAG-tagged ubiquitin or 3 Â FLAG-tagged NEDD8 revealed that the patterns of total ubiquitinated proteins and total NEDDylated proteins were distinct (Supplementary Figure S1G) , confirming that ubiquitin and NEDD8 are specifically recognized by their corresponding enzymatic systems even when overexpressed. Furthermore, NEDDylation of endogenous E2F1 was also detected with the expression of only His 6 -NEDD8 (Figure 1b) .Importantly, NEDDylation of E2F1 markedly reduced upon the treatment with the NEDD8 E1 inhibitor MLN4924 29 (Supplementary Figure S1H) . These results thus suggest that the conjugation of NEDD8 to E2Fs is a bona fide modification.
E2F1 is NEDDylated in vitro
Each ubiquitin-like protein is conjugated to substrate proteins by a specific triplet chain of enzymes (E1, E2 (and E3)). To demonstrate that E2F1 is a substrate for NEDD8 modification, we incubated recombinant E2F1 with different E1 and E2 proteins, along with either ubiquitin or NEDD8. Incubation of E2F1 with APP-BP1/Uba3 and Ubc12, which are E1 and E2 enzymes that specifically catalyze NEDDylation, resulted in the appearance of slower-migrating Figure 1 . E2F1 is NEDDylated in cells and in vitro. (a) HEK293T cells were transfected with green fluorescent protein (GFP) along with a plasmid encoding either His 6 -tagged ubiquitin (His-Ub), NEDD8 (His-NEDD8), or the corresponding empty vector, along with a plasmid for E2F1. Total cell lysates (bottom panels), as well as His 6 -tagged proteins purified there from (top panels) were subjected to immunoblot analysis with antibodies to E2F1. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and GFP were examined as loading and transfection controls, respectively. Asterisks represent nonspecifically precipitated proteins. Data presented are representative of three independent experiments. (b) HEK293T cells were transfected with a plasmid encoding either His-Ub, His-NEDD8 or the corresponding empty vector. Cells were analyzed as described above. Data presented are representative of five independent experiments. (c) Recombinant E2F1 or p53 was mixed with the indicated purified proteins and incubated for 30 min at 37 1C in the presence of ATP. The reaction mixtures were then subjected to immunoblot analysis with antibodies to E2F1 or to p53. Data presented are representative of three independent experiments. bands in the presence of NEDD8 but not in the presence of ubiquitin (Figure 1c) . These results thus further demonstrate that NEDD8 and ubiquitin are strictly discriminated, even in vitro, and that E2F1 is indeed a direct substrate for NEDDylation.
E2F1 is NEDDylated on multiple lysine residues We next aimed to identify the lysine residues of E2F1 to which the NEDD8 moiety is conjugated. To do this, we constructed a series of E2F1 mutants where lysines are replaced with arginines ( Figure 2a ) and examined whether these mutations abrogated NEDDylation unexpectedly NEDDylation of E2F1 was completely abolished only when all of the 14 lysines were replaced (Figure 2b, c) . These results indicate that multiple lysine residues of E2F1 are targets for NEDD8 conjugation, in contrast to cullins 24 or pVHL 30 in which only a single lysine is targeted for NEDDylation.
SENP8 deNEDDylates E2F1
SENP8 is a cysteine protease that functions as a specific NEDD8 isopeptidase and deNEDDylates p53, 31 p73, 32 BCA3, 33 and ribosomal protein L11. 34 We examined whether E2F1 is also a substrate for SENP8-mediated deNEDDylation. Overexpression of SENP8 resulted in the almost complete disappearance of the electrophoretically shifted pattern of bands corresponding to NEDDylated E2F1 (Figure 3) , suggesting that SENP8 deNEDDylates E2F1 in vivo. Overexpression of SENP8 also resulted in the deNEDDylation of E2F2, E2F3, E2F4 and DP1 (Supplementary Figure S2A-D) . Moreover, overexpression of SENP8 eliminated most of the signals corresponding to NEDDylated proteins without affecting those of ubiquitinated proteins (Supplementary Figure.  S2E ), indicating that SENP8 strictly discriminates NEDD8 from ubiquitin.
NEDDylation of E2F1 is reduced in response to DNA damage in a SENP8-dependent manner Given that the amount of SENP8 increases in response to DNA damage 25 and that we found that E2Fs are deNEDDylated by SENP8, we next asked whether NEDDylation of E2F1 is affected following DNA damage. Treatment of H1299 cells with genotoxic agent resulted in a marked decrease in the NEDDylation of E2F1 but not in the ubiquitination of E2F1 (Figure 4a ). We then examined whether the reduction in the level of E2F1 NEDDylation associated with DNA damage is dependent on SENP8. Knockdown of SENP8 attenuated the reduction in E2F1 NEDDylation induced by doxorubicin (Figures 4b-c and Supplementary Figure. S3 ). These data suggest that E2F1 undergoes deNEDDylation in response to DNA damage, in a manner dependent on SENP8. 
SENP8 enhances E2F1 activity in a target gene-specific manner
We then examined the effect of NEDDylation on the transactivation activity of E2F1 using luciferase reporter assays. To do this, we made use of reporter plasmids encoding firefly luciferase under the control of either the p73 or the E2F2 promoters, which are both targets of E2F1. E2F1 expression activated both reporters. SENP8 expression enhanced p73-luciferase activity (Figure 5a ), but had little effect on E2F2-luciferase activity ( Figure 5b ). We were unable to directly confirm that the effect of SENP8 was due to deNEDDylation from the lysines on E2F1, as expression of the E2F1 mutant in which all of 14 lysine residues are mutated did not activate the p73-luciferase reporter at all (data not shown). However, our results are consistent with the hypothesis that NEDDylation negatively regulates the transactivation activity of E2F1 at certain target genes, including p73.
SENP8 is required for the induction of p73 expression and apoptosis by E2F1 Next, we asked whether endogenous levels of SENP8 can affect E2F1 transcriptional activity. H1299 cells stably expressing a fusion protein of the estrogen receptor (ER) and E2F1 were transfected with control or SENP8 small interfering RNAs (siRNAs) and exposed to 4-hydroxytamoxifen (4-OHT) for 2 h in the presence of cycloheximide. We then examined for the expression of E2F1 target genes by reverse transcription and quantitative PCR (qPCR) analysis. Treatment with 4-OHT increased p73 mRNA level, which was attenuated by knockdown of SENP8 (Figure 6a ). Expression of the NOXA gene, another proapoptotic target of E2F1, 11 was affected by 4-OHT and SENP8 siRNA in a manner similar to that of the p73 gene. By contrast, SENP8 knockdown did not reduce the expression of E2F1 target genes that are involved in cell proliferation, such as Cyclin E, CDC25A, E2F2 or AXIN2. 35, 36 Given that cycloheximide blocks protein synthesis, the increased mRNAs observed after 4-OHT treatment are likely attributable to a direct effect of ER-E2F1. These results thus suggest that NEDDylation negatively regulates E2F1 activity in a target gene-specific manner.
Given that SENP8 modifies the transcription of proapoptotic genes, we measured the effect of knocking down SENP8 expression on E2F1-dependent apoptosis. U2OS cells stably expressing ER-E2F1 were exposed to 4-OHT and apoptosis was monitored by detecting the cleaved form of poly(ADP-ribose) polymerase. SENP8 knockdown greatly attenuated the increase of cleaved poly(ADP-ribose) polymerase induced by ER-E2F1 activation ( Figure. 6b) . Consistently, SENP8 knockdown attenuated the induction of p73 expression by ER-E2F1 but not that of Cyclin E or caspase-3 expression. The amount of ER-E2F1 was not affected by SENP8 knockdown (Figure 6b ), further suggesting that NEDDylation of E2F1 does not reduce E2F1 protein levels but rather attenuates E2F1 activity in a target gene-specific manner. We obtained similar results with SAOS-2 cells ( Figure. 6c) , which are null for the p53 gene. Our results suggest that SENP8 promotes the induction of apoptosis by E2F1 in a manner independent of p53.
We also examined the effect of SENP8 knockdown on cell cycle progression induced by E2F1. SAOS-2 cells stably expressing ER-E2F1 was treated with 4-OHT and their cell cycle profile were measured by flow cytometry. Activation of ER-E2F1 greatly increased the population of cells in S and G 2 -M phases of the cell cycle in a manner largely insensitive to SENP8 knockdown (Figure 6d and Supplementary Figure. S4 ). These results thus demonstrate that NEDDylation of E2F1 specifically inhibits its ability to induce apoptosis without affecting its role in cell cycle progression.
SENP8 is required for the induction of p73 expression and apoptosis in response to DNA damage Our results suggest that deNEDDylation is required for E2F1 to induce the expression of p73 and promote apoptosis. We next asked whether SENP8 is also necessary for p73 expression and apoptosis induced by DNA damage, which have also been shown to be dependent on E2F1. 21 Exposure of H1299 cells to doxorubicin resulted in upregulation of p73 and NOXA mRNAs, and these effects were attenuated by SENP8 knockdown (Figure 7a ). By contrast, SENP8 knockdown did not reduce the expression of the E2F1 target genes such as Cyclin E, CDC25A or AXIN2 in the absence or presence of doxorubicin treatment. Furthermore, the expression of SENP8 mRNA was increased by doxorubicin treatment, consistent with previous observations (Figure 7a) . 25 Exposure of SAOS-2 cells to doxorubicin resulted in poly(ADP-ribose) polymerase cleavage, which was similarly attenuated by SENP8 knockdown (Figure 7b ). Taken together, these results suggest that deNEDDylation of E2F1 is indeed important for the response to DNA damage mediated by E2F1, even in the absence of p53.
SENP8 promotes interaction between E2F1 and MCPH1
To further elucidate the mechanism by which SENP8 enhances E2F1 activity, we examined the effect of SENP8 on the interaction of E2F1 with its cofactors. We focused on MCPH1 because both SENP8 and MCPH1 affect the activity of E2F1 at a subset of its target genes, including the p73 gene. 23 Expression of SENP8 led to an increase in the amount of wild-type E2F1 that was coimmunoprecipitated with 3 Â FLAG-tagged MCPH1 (Figure 8a) . By contrast, co-immunoprecipitation of the 14KR mutant of E2F1 was unaffected by SENP8 overexpression. These results suggest that NEDDylation of E2F1 interferes with its interaction with MCPH1, and that the site of action of SENP8 is indeed E2F1.
The proapoptotic function of E2F1 depends on the marked box of E2F1. 16 Jab1, a factor that binds the marked box of E2F1, is necessary for E2F1 to induce apoptosis. 15 We therefore asked whether the NEDDylation status of E2F1 might affect the interaction between E2F1 and Jab1. However, we could not detect the association of E2F1 with Jab1 in the cell types examined in the present study (Figure 8e ), suggesting that Figure 3 . E2F1 is deNEDDylated by SENP8. HEK293T cells were transfected with plasmids encoding GFP and His 6 -NEDD8, along with a plasmid encoding E2F1, and either a plasmid encoding HAtagged SENP8 or the corresponding empty plasmid. Cell lysates and His 6 -tagged proteins purified from there were then subjected to immunoblot analysis with antibodies to E2F1. Asterisks indicate nonspecifically precipitated proteins. Data presented are representative of four independent experiments. modulation of the E2F1-Jab1 interaction is not the mechanism through which NEDDylation regulates E2F1 activity.
Ying Yang 1 transcription factor has also interacts with E2F1 and contributes to p73 expression. 37 However, the interaction between E2F1 and Ying Yang 1 was not affected by SENP8 expression (Figure 8b ). We also examined the effect of SENP8 expression on the interaction of E2F1 with conventional cofactors such as pRB, p300 and PCAF and found no effect on them (Figures 8c-e) . 
-test).
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SENP8 is required for E2F1-MCPH1 interaction induced by DNA damage
The interaction between E2F1 and MCPH1 is increased in response to DNA damage. 23 We showed above that SENP8 enhances this interaction, and that SENP8 is required for deNEDDylation of E2F1, as well as for the induction of p73 expression in response to DNA damage. We next sought to determine whether SENP8-mediated deNEDDylation of E2F1 leads to the increase in the E2F1-MCPH1 interaction induced by DNA damage. Consistent with previous studies, we found that the association between E2F1 and MCPH1 increased following etoposide or doxorubicin treatment. 23 Knockdown of SENP8 abolished this effect (Figure 8f) , suggesting that deNEDDylation of E2F1 by SENP8 is required to enhance the E2F1-MCPH1 interaction following DNA damage. We conclude that DNA damage triggers SENP8-mediated deNEDDylation of E2F1, which enhances the interaction of E2F1 with MCPH1 and thereby results in transactivation of the p73 gene and in induction of apoptosis (Figure 9 ).
DISCUSSION
How does E2F1 avoid inducing cell death when it becomes activated during cell cycle progression, yet faithfully induce cell death in response to cellular stresses? In the present study, we describe a novel post-translational modification of E2F1, NEDDylation, which negatively regulates the proapoptotic activity of E2F1 at a specific subset of target genes, including p73. Our data suggest that NEDDylation of E2F1 leads to a disruption of the interaction between E2F1 and MCPH1, and therefore to downregulation of E2F1 activity. NEDDylation appears to inhibit the ability of E2F1 to induce cell death, when cells undergo proliferation in the absence of stress. By contrast, we found that DNA damage resulted in a SENP8-dependent deNEDDylation of E2F1. We found that SENP8 was required for reinforcement of the E2F1-MCPH1 interaction, and for the subsequent induction of p73 expression and apoptosis. Our data suggest that NEDD8 must be removed from E2F1 so that it can induce apoptosis in response to DNA damage, and imply that NEDDylation of E2F1 acts as a molecular switch that confers target preference on E2F1.
The molecular signaling pathway identified here provides an ample backdrop for future studies into the mechanisms of E2F1-dependent apoptosis. Apoptosis induced by E2F1 overexpression is attenuated in the presence of serum, a mechanism that is dependent on the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway. 15, 16 It will therefore be interesting to examine the effects of serum stimulation and phosphoinositide 3-kinase-Akt signaling on the NEDDylation status of E2F1.
Although NEDDylation of E2F1 might directly regulate the association of E2F1 with its binding partners such as MCPH1 or Jab1, it might also regulate E2F1 activity indirectly by affecting other post-translational modifications of E2F1. Lysine residues, which are targeted by NEDD8, are also the sites for several other post-translational modifications such as acetylation, methylation, ubiquitination and sumoylation. E2F1 is acetylated on lysines 117, 120 and 125 in response to DNA damage, with such acetylation being required for E2F1 stabilization. [38] [39] [40] In fact, acetylation of E2F1 has been found to be required for its recruitment to and activation of the p73 gene promoter. 22 Given that we have now shown that the acetylation sites of E2F1 are also NEDDylated (Figure 2c) , it is possible that NEDDylation might inhibit E2F1 activity at the p73 gene promoter by competing with acetylation for lysine residues. However, this competition between acetylation and NEDDylation does not seem to be operating in our system, as the K117/120/125R mutant of E2F1 interacted with MCPH1 and activated the p73 gene promoter to an extent similar to that observed with wild-type E2F1 (data not shown). This indicates that acetylation does not account for the activation of p73 gene promoter after E2F1 deNEDDylation.
Given that our data show that E2F1 is both ubiquitinated and NEDDylated on multiple lysine residues, we examined the effect of NEDDylation on ubiquitination. Unexpectedly, both downregulation and upregulation of E2F1 NEDDylation by forced expression of SENP8 and SENP8 knockdown, respectively, enhanced E2F1 ubiquitination (data not shown), suggesting the existence of a complex relationship between these two modifications. Given that neither overexpression nor knockdown of SENP8 affected E2F1 protein stability, the increased ubiquitination of E2F1 associated with changes in the level of NEDDylation might not trigger its proteolysis by the proteasome. Although E2F1 is sumoylated, 28 the relevance of this modification is unknown. It will be of interest to examine the effect of sumoylation on E2F1 activity and its interaction with other post-translational modifications.
In most human cancers, the p53 gene is either mutated or inactivated by indirect mechanisms. 41 Cell signaling that results in apoptosis in the absence of p53 might thus be expected to be of therapeutic value. E2F1 is important for apoptosis induced by DNA damage or oncogenic stress. 19, 21, 42, 43 Mice deficient in E2F1 are prone to the development of a wide spectrum of cancers, 44, 45 indicating that E2F1 functions as a tumor suppressor. E2F1 induces apoptosis in both p53-dependent and p53-independent manners, 46 with the E2F1-p73 axis being able to induce apoptosis independently of p53. Activation of proapoptotic signaling downstream of E2F1 without triggering cell proliferation might therefore be beneficial in the context of antitumor therapy. Our present results suggest that NEDDylation of E2F1 specifically downregulates its apoptotic function. Comparison of the NEDDylation state of E2F1 and the activity of SENP8 between cancerous tissue and neighboring normal tissue may thus be warranted. A recently developed fluorescence resonance energy transfer probe 47 might make it possible to monitor the activity of SENP8 during tumorigenesis, as well as during development. On the other hand, disruption of NEDD8 conjugation to E2F1 is a possible therapeutic strategy for cancers in which p53 is inactivated.
In conclusion, we have identified NEDDylation as a new mechanism for regulation of the proapoptotic activity of E2F1. We find that other E2F family members also undergo NEDDylation, adding a group of important transcription factors to the list of substrates for NEDDylation, only a few of which have been identified and characterized to date.
MATERIALS AND METHODS
Cell culture and transfection
All cell lines were maintained under a humidified atmosphere of 5% CO 2 at 37 1C in medium supplemented with 10% heat-inactivated fetal bovine serum (Cancera). HEK293T, U2OS and SAOS-2 cells were maintained in Dulbecco's modified Eagle's medium (Sigma, St Louis, MO, USA). Ecotropic virus-packaging (Plat-E) cells were maintained in Dulbecco's modified Eagle's medium supplemented with puromycin and blastcidin S, 48 and H1299 cells in RPMI 1640 medium (Gibco, Carlsbad, CA, USA). Cell transfection with DNA plasmids was performed with the use of the GeneJuice Transfection Reagent (Novagen, Darmstadt, Germany).
Establishment of cells stably expressing ER-E2F1
For the production of retroviruses encoding ER-E2F1, Plat-E cells were transfected with pBabe-puro-ER-E2F1 (kindly provided by K Helin) and then cultured for 2 days at 32 1C. Retroviral particles were collected from the culture supernatant by centrifugation at 6000 Â g for 16 h at 4 1C and were resuspended in serum-free Dulbecco's modified Eagle's medium. U2OS, SAOS-2 or H1299 cells were transiently transfected with pcDNA3.1-HA-Slc7a1, infected with retroviruses encoding ER-E2F1, and subjected to selection in the presence of puromycin for 3 days.
RNA interference (RNAi) reagents and cell expression A Stealth Select siRNA specific for human SENP8 mRNA (SENP siRNA #1, corresponding to SENP8-HSS133649), a Stealth RNAi Negative NEDDylation inhibits E2F1-mediated apoptosis I Aoki et al Control Low GC Duplex (control siRNA Low), and a Stealth RNAi Negative Control Medium GC Duplex (control siRNA Med) were obtained from Invitrogen (St Louis, MO, USA). Silencer Select siRNAs for human SENP8 (SENP siRNAs #2 and #3, corresponding to s223269 and s223270, respectively) and Silencer Select Negative Control #2 were obtained from Ambion (St Louis, MO, USA). Cells were transfected with siRNAs with the use of Lipofectamine RNAiMAX (Invitrogen).
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Purification of His 6 -tagged conjugates His 6 -tagged conjugates were purified as described previously 49 with modifications. HEK293T cells (2 Â 10 5 ) that had been transfected for 24 h were harvested in ice-cold phosphate-buffered saline (PBS) and lysed in 500 ml of a solution containing 6 M guanidinium-HCl, 0.1 M sodium phosphate buffer (pH 8.0), and 5 mM imidazole. The lysates were subjected to ultrasonic treatment to reduce their viscosity, mixed with 10 ml of Talon resin (Clontech, Otsu, Japan), and incubated for 1 h at 4 1C with rotation. The resin was then washed twice with 500 ml of Talon wash buffer (300 mM NaCl, 50 mM sodium phosphate buffer (pH 8.0), 5 mM imidazole) and boiled in 50 ml of 1 Â SDS sample buffer. The samples were subjected to immunoblot analysis.
In vitro NEDD8 or ubiquitin conjugation assay High-five insect cells were infected with baculoviruses encoding His 6 -tagged mouse Uba1 or His 6 -tagged APP-BP1, together with that encoding T7-tagged Uba3 (kindly provided by K Iwai). His 6 -tagged forms of Ubc12, (a) HEK293T cells were transfected with plasmids for 3 Â FLAG-tagged MCPH1, for wild-type or 14KR mutant forms of E2F1, for SENP8, and for GFP as indicated. Cell lysates were subsequently subjected to immunoprecipitation (IP) with gel-conjugated antibodies to FLAG, and the resulting precipitates, as well as the cell lysates were examined by immunoblot analysis with antibodies to the indicated proteins. Asterisk represent nonspecifically precipitated protein. (b) HEK293T cells were transfected with plasmids encoding E2F1 and GFP in the absence or presence of plasmids for HA-tagged Ying Yang 1 and FLAG-tagged SENP8. Cell lysates were subjected to IP with antibodies to HA, and the resulting precipitates, as well as the cell lysates were examined by immunoblot analysis with antibodies to the indicated proteins. (c) HEK293T cells were transfected with plasmids for E2F1, as well as HA-tagged SENP8 or NEDD8 as indicated, and cell lysates were subjected to IP with antibodies to pRB or with control immunoglobulin G (IgG). The resulting precipitates, as well as the cell lysates were examined by immunoblot analysis with antibodies to the indicated proteins. (d) HEK293T cells were transfected with plasmids for E2F1, SENP8, GFP and either FLAGtagged pRB or FLAG-PCAF, as indicated. Cell lysates were then subjected to IP with antibodies to FLAG, and the resulting precipitates and the cell lysates were analyzed as described above. (e) HEK293T cells were transfected with plasmids for E2F1, GFP, 3 Â FLAG-tagged SENP8 and either HA-tagged Jab1 or HA-p300, as indicated. Protein interactions were analyzed as described in (b). (f ) HEK293T cells were transfected first for 24 h with SENP8 or control siRNAs (10 nM) and then for 24 h with plasmids for E2F1 and GFP and with or without a plasmid for 3 Â FLAGtagged MCPH1. The cells were then incubated in the absence or presence of 10 mM etoposide (Etop) or 2 mM doxorubicin (DXR) for 12 h, after which cell lysates were subjected to IP with antibodies to FLAG. The resulting precipitates, as well as the cell lysates were examined by immunoblot analysis with antibodies to the indicated proteins. Data presented are representative of three independent experiments.
UbcH5b and NEDD8 were expressed in bacteria. His 6 -tagged proteins were purified from cell extracts with the use of ProBond resin (Invitrogen). Glutathione S-transferase fusion proteins of E2F1 or p53 were expressed in bacteria and purified with the use of glutathione-Sepharose 4B (GE Healthcare, Piscataway, NJ, USA), and the glutathione S-transferase moiety was then cleaved from the fusion proteins with PreScission Protease (GE Healthcare). E2F1 or p53 (50 ng) was incubated for 30 min at 37 1C with 200 ng of E1 (APP-BP1/Uba3 or Uba1), 200 ng of E2 (Ubc12 or UbcH5b) and 500 ng of NEDD8 or 5mg of ubiquitin (Sigma) in a 25 ml reaction mixture including 50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 2 mM dithiothreitol and 2 mM ATP. The reactions were terminated by the addition of SDS sample buffer, and the samples were subjected to immunoblot analysis.
Immunoprecipitation
HEK293T cells were harvested in ice-cold PBS and lysed in a solution containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM b-glycerophosphate, 5 mM ethylene glycol tetraacetic acid, 5 mM NaF, 1 mM sodium pyrophosphate, 0.1% Triton X-100, 1 mM dithiothreitol, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride and aprotinin (1 mg/ml). Cell lysates were then incubated for 1 h at 4 1C with anti-FLAG M2 Affinity Gel, after which the gel was washed twice with ice-cold PBS and boiled in 50 ml of 1 Â SDS sample buffer.
Immunoblot analysis
Samples were fractionated by SDS-polyacrylamide gel electrophoresis, and the separated proteins were transferred to an Immobilon-P membrane (Millipore, Darmstadt, Germany) and exposed consecutively to primary antibodies overnight at 4 1C and followed by horseradish peroxidaseconjugated secondary antibodies (GE Healthcare) for 1 h at room temperature. Immune complexes were detected with chemiluminescence reagents containing 1.25 mM luminol, 198 mM p-coumaric acid, 0.009% H 2 O 2 , and 100 mM Tris-HCl (pH 8.5). Data presented are representative of at least three independent experiments.
Dual luciferase reporter assay HEK293T cells (2 Â 10 4 ) were transfected for 24 h with 100 ng of p73-or E2F2-luciferase reporter constructs, 10 ng of pGL4-Tk-Renilla and 5 ng of pcDNA3-E2F1 in the absence or presence of 100 ng of pCAGEN-HA-SENP8. Both firefly and Renilla luciferase activities were then measured with the use of a Dual Luciferase Reporter Assay System (Promega) and with a MiniLumat LB 9506 instrument (Berthold Technologies, Bad Wildbad, Germany).
Reverse transcription-PCR analysis
Total RNA was isolated from cells with RNAiso (Takara, Otsu, Japan). Reverse transcription was performed with 2 mg of total RNA, oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers (Invitrogen), and ReverTra Ace (Toyobo, Osaka, Japan). The resulting complementary DNA was subjected to real-time PCR analysis with SYBR Premix Ex Taq (Takara) and with a LightCycler 480 (Roche, Basel, Switzerland). The abundance of target mRNAs was normalized by that of PPIA mRNA. Primers are listed in Supplemental Data.
Flow cytometry
Cells were dissociated with trypsin and fixed in 70% ethanol in PBS. The cells were then reconstituted in PBS containing propidium iodide (5 mg/ml) (Sigma) and RNase (100 mg/ml) (Sigma), and cell cycle profiles were determined with a FACScalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) and ModFit LT software (Verity Software House, Topsham, ME, USA). Figure 9 . Model for regulation of E2F1 by deNEDDylation in response to DNA damage. In the absence of DNA damage, E2F1 is NEDDylated and is dissociating from MCPH1 and hence E2F1 activity on a subset of its target genes including p73 is inhibited. By contrast, once DNA is damaged, expression of SENP8 increases and E2F1 is deNEDDylated, resulting in the enhancement of the interaction between E2F1 and MCPH1 and thereby the activation of E2F1 toward such target genes as p73, which triggers the induction of apoptosis.
